YS Biopharma Co. Ltd.’s PIKA rabies vaccine has been granted phase 3 clinical trial approval from the Food and Drug Administration of the Philippines.The phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety…
Source: www.labiotech.eu – Read more
Microsoft Warns Of XCSSET MacOS Malware That Is Now More Dangerous Than Ever – HotHardware
Microsoft Warns Of XCSSET MacOS Malware That Is Now More Dangerous Than Ever HotHardware
